Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2173476Generated: October 31, 2026

5-tert-Butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine → 5-tert-Butyl-3-(2-chloro-benzyl)-7-(4,4-difluoro-piperidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

https://huagongshe.com/reaction/2173476

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-tert-Butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 1433953—
Reactant4,4-Difluoropiperidine hydrochlorideHCID 2758351—
Reactant5-tert-butyl-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 86683284—
Product5-tert-Butyl-3-(2-chloro-benzyl)-7-(4,4-difluoro-piperidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 71557064—

Reaction Steps

In analogy to the procedure described for the synthesis of 5-tert-butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 1, step c), the title compound was prepared from 5-tert-butyl-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 4,4-difluoropiperidine hydrochloride and isolated as light-yellow gum (10.9 mg, 55%). MS(m/e): 421.4 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09056866B2
Source datasetuspto-grants-2015_06
ORD IDord-83a5218bd83c45b1a62d2ca4eb2868fe
Source noteuspto-grants-2015_06